Wednesday, July 19, 2017 3:15:52 PM
Cytrx is not the first ticker that had some misleading trial results released that caused a huge share price drop, only later to get run up in dollars again from 50 cents. There shouldn't be Tutes holding shares if Aldox was worthless like some trying to bash this.
Don't forget we have a product that completed a phase 3 with success. Phase 1 to address safety, phase 2 to show effectiveness, and a phase 3 to compare with existing treatment with positive results as well as a clear FDA approval path.
For once, I am actually hoping SK get that deal through even if it was 4$ lol.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM